Page last updated: 2024-08-25

s20098 and Autism Spectrum Disorder

s20098 has been researched along with Autism Spectrum Disorder in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Alamiri, B; Hasan, AE; Jamali, MA; Naguy, A; Pridmore, S1
Ballester, P; Belda, C; Fernández, E; Inda, MD; Javaloyes, A; Martínez, MJ; Morales, D; Muriel, J; Peiró, AM; Richdale, AL; Toral, N1
Kumar, H; Sharma, B; Sharma, BM1

Trials

1 trial(s) available for s20098 and Autism Spectrum Disorder

ArticleYear
Evaluation of agomelatine for the treatment of sleep problems in adults with autism spectrum disorder and co-morbid intellectual disability.
    Journal of psychopharmacology (Oxford, England), 2019, Volume: 33, Issue:11

    Topics: Acetamides; Adult; Autism Spectrum Disorder; Circadian Rhythm; Cross-Over Studies; Double-Blind Method; Female; Humans; Hypnotics and Sedatives; Intellectual Disability; Male; Middle Aged; Sleep Wake Disorders; Time Factors; Young Adult

2019

Other Studies

2 other study(ies) available for s20098 and Autism Spectrum Disorder

ArticleYear
Agomelatine Monotherapy for Autism-A Case Report.
    Psychopharmacology bulletin, 2022, 10-27, Volume: 52, Issue:4

    Topics: Antipsychotic Agents; Aripiprazole; Autism Spectrum Disorder; Autistic Disorder; Humans; Risperidone

2022
Benefits of agomelatine in behavioral, neurochemical and blood brain barrier alterations in prenatal valproic acid induced autism spectrum disorder.
    Neurochemistry international, 2015, Volume: 91

    Topics: Acetamides; Animals; Anticonvulsants; Autism Spectrum Disorder; Blood-Brain Barrier; Exploratory Behavior; Female; Gastrointestinal Motility; Interpersonal Relations; Motor Activity; Neuroprotective Agents; Oxidative Stress; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Serotonin; Valproic Acid

2015